Literature DB >> 22038847

Protective effects of passively transferred merozoite-specific antibodies against Theileria equi in horses with severe combined immunodeficiency.

Robert H Mealey1, Lowell S Kappmeyer, Massaro W Ueti, Bettina Wagner, Donald P Knowles.   

Abstract

Theileria equi immune plasma was infused into young horses (foals) with severe combined immunodeficiency. Although all foals became infected following intravenous challenge with homologous T. equi merozoite stabilate, delayed time to peak parasitemia occurred. Protective effects were associated with a predominance of passively transferred merozoite-specific IgG3.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22038847      PMCID： PMC3255952          DOI： 10.1128/CVI.05301-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  23 in total

1.  Maintenance of foals with combined immunodeficiency: causes and control of secondary infections.

Authors:  L E Perryman; T C McGuire; T B Crawford
Journal:  Am J Vet Res       Date:  1978-06       Impact factor: 1.156

2.  Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses.

Authors:  R H Mealey; D G Fraser; J L Oaks; G H Cantor; T C McGuire
Journal:  Clin Immunol       Date:  2001-11       Impact factor: 3.969

3.  Combined immunodeficiency in horses: characterization of the lymphocyte defect.

Authors:  T C McGuire; K L Banks; M J Poppie
Journal:  Clin Immunol Immunopathol       Date:  1975-03

4.  The complement-fixation reaction in eguine infectious anemia: demonstration of inhibition by IgG (T).

Authors:  T C McGuire; G L Van Hoosier; J B Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

5.  The complete map of the Ig heavy chain constant gene region reveals evidence for seven IgG isotypes and for IgD in the horse.

Authors:  Bettina Wagner; Donald C Miller; Teri L Lear; Douglas F Antczak
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

6.  Expression of equi merozoite antigen 2 during development of Babesia equi in the midgut and salivary gland of the vector tick Boophilus microplus.

Authors:  Massaro W Ueti; Guy H Palmer; Lowell S Kappmeyer; Glen A Scoles; Donald P Knowles
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

7.  Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection.

Authors:  L E Perryman; K I O'Rourke; T C McGuire
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Evolution of the six horse IGHG genes and corresponding immunoglobulin gamma heavy chains.

Authors:  Bettina Wagner; Irene Greiser-Wilke; Anja K Wege; Andreas Radbruch; Wolfgang Leibold
Journal:  Immunogenetics       Date:  2002-07-04       Impact factor: 2.846

9.  Continuous cultivation of equine lymphocytes: evidence for occasional T cell-like maturation events in horses with hereditary severe combined immunodeficiency.

Authors:  N S Magnuson; L E Perryman; C R Wyatt; T Ishizaka; P H Mason; A E Namen; K L Banks; J A Magnuson
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

10.  Equine piroplasmosis associated with Amblyomma cajennense Ticks, Texas, USA.

Authors:  Glen A Scoles; H Joel Hutcheson; Jack L Schlater; Steven G Hennager; Angela M Pelzel; Don P Knowles
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883
View more
  2 in total

1.  Lymphocytes and macrophages are infected by Theileria equi, but T cells and B cells are not required to establish infection in vivo.

Authors:  Joshua D Ramsay; Massaro W Ueti; Wendell C Johnson; Glen A Scoles; Donald P Knowles; Robert H Mealey
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

Review 2.  Twenty Years of Equine Piroplasmosis Research: Global Distribution, Molecular Diagnosis, and Phylogeny.

Authors:  Sharon Tirosh-Levy; Yuval Gottlieb; Lindsay M Fry; Donald P Knowles; Amir Steinman
Journal:  Pathogens       Date:  2020-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.